What is Vascular Dynamics?
Vascular Dynamics is a pioneering medical technology firm dedicated to addressing life-threatening conditions that remain underserved by conventional clinical interventions. At the core of its innovation is the MobiusHD technology, a groundbreaking endovascular device designed to leverage the body's natural baroreflex mechanism. By modulating the autonomic nervous system to restore sympathetic balance, the company provides a novel therapeutic pathway for patients with complex cardiovascular needs. This focus on autonomic regulation positions Vascular Dynamics as a leader in the intersection of neuro-modulation and vascular medicine, with clinical evaluations currently underway to validate the efficacy of its platform in real-world settings.
How much funding has Vascular Dynamics raised?
Vascular Dynamics has raised a total of $55.8M across 4 funding rounds:
Series A
$8.6M
Series B
$16.8M
Series C
$10.4M
Other Financing Round
$20M
Series A (2012): $8.6M, investors not publicly disclosed
Series B (2014): $16.8M led by MedFocus Fund, LLC, Rainbow Medical, and HBM Healthcare Investments
Series C (2017): $10.4M, investors not publicly disclosed
Other Financing Round (2022): $20M featuring HBM Healthcare Investments, Rainbow Medical, and Invus
Key Investors in Vascular Dynamics
HBM Healthcare Investments
HBM Healthcare Investments is a publicly traded investment company focused on the global healthcare sector, with a diversified portfolio of private and publicly listed companies.
Rainbow Medical
Rainbow Medical is a private operational investment company that invents and grows startup companies, developing breakthrough medical devices for diverse unmet medical needs.
Invus
Invus Group is an investment firm specializing in financial advice, investment services, and consulting services, with a long-standing history of supporting innovative enterprises.
What's next for Vascular Dynamics?
With the successful closure of this major strategic investment, Vascular Dynamics is well-positioned to accelerate its clinical development programs and scale its operational capabilities. The company's strategic roadmap likely involves expanding the clinical evidence base for the MobiusHD system, a critical step toward securing regulatory approvals and broader market adoption. As the firm transitions into this next phase of growth, the focus will remain on refining its endovascular solutions and exploring commercialization pathways that address the significant unmet needs in the global healthcare market. The continued support from specialized healthcare investors provides the necessary runway to navigate the complexities of medical device commercialization while maintaining a commitment to patient-centric innovation.
See full Vascular Dynamics company page
